taxonomy (1)
protein (1)
source (2)
structure (0)
composition (33)
disease (2)
reference (2)
site (6)
peptide (6)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:4 HexNAc:3 dHex:3 (avg mass : 1714.5989 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2678.4515 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:6 HexNAc:6 NeuAc:3 (avg mass : 3083.8134 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 (avg mass : 3084.8415 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 (avg mass : 3538.2418 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 (avg mass : 3829.4997 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
Reference
- Laminin subunit beta-1 / Homo sapiens
Reported glycosite
- NSNACK (6aa)
- GTNYTVR (7aa)
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
- LSDTTSQSNSTAK (13aa)
- VNASTTEPNSTVEQSALMR (19aa)
- MEMPSTPQQLQNLTEDIR (18aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked (avg mass : 1714.5989)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:3 HexNAc:6 / N-Linked (avg mass : 1723.6125)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked (avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
- VNASTTEPNSTVEQSALMR (19aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2135.9602)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked (avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- VNASTTEPNSTVEQSALMR (19aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- CVCNYLGTVQEHCNGSDCQCDK (22aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- VNASTTEPNSTVEQSALMR (19aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
- LSDTTSQSNSTAK (13aa)
- VNASTTEPNSTVEQSALMR (19aa)
-
- Hex:6 HexNAc:5 dHex:3 / N-Linked (avg mass : 2445.2737)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2678.4515)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked (avg mass : 2736.5316)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked (avg mass : 2809.583)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- GTNYTVR (7aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:6 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3083.8134)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- MEMPSTPQQLQNLTEDIR (18aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 / N-Linked (avg mass : 3084.8415)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- NSNACK (6aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Laminin subunit beta-1 / Homo sapiens
- LSDTTSQSNSTAK (13aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 / N-Linked (avg mass : 3538.2418)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- MEMPSTPQQLQNLTEDIR (18aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 / N-Linked (avg mass : 3829.4997)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Laminin subunit beta-1 / Homo sapiens
- MEMPSTPQQLQNLTEDIR (18aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
